Moffet A (ed): Clarke's Isolation and Identification of Drugs (ed 2). London, Pharmaceutical Press, 1986
2.
Reves J., Glass P.: Nonbarbiturate intravenous anesthetics, in Miller R (ed): Anesthesia. New York, NY, Churchill Livingstone, 1990, pp 243-279
3.
Greenblatt D. , Shader R., Abernethy D.: Medical intelligence drug therapy: Current status of benzodiazepines. N Engl J Med309:354-358, 1983
4.
Greenblatt D. , Shader R., Abernethy D.: Current status of benzodiazepines. N Engl J Med309:354-358, 1983
5.
Gerecke M.: Chemical structure and properties of midazolam compared with other benzodiazepines . Br J Clin Pharmacol16:11S-16S, 1983
6.
Greenblatt D. , Arendt R., Abernethy D., et al: In vitro quantitation of benzodiazepine lipophilicity: Relation to in vivo distribution. Br J Anaesth55:985-989, 1983
7.
Arendt R., Greenblatt D., de Jong R., et al: In vitro correlation of benzodiazepine cerebrospinal fluid uptake, pharmacodynamic action and peripheral distribution. J Pharmacol Exp Ther227:98-106, 1983
8.
Stoelting R.: Pharmacology and Physiology in Anesthetic Practice (ed 2). Philadelphia, PA, Lippincott , 1991
9.
Greenblatt D. , Shader RI, Divoll M., et al: Benzodiazepines: A summary of pharmacokinetic properties. Br J Clin Pharmacol11:11S-16S, 1981
10.
Reves J.: Benzodiazepines, in Prys-Roberts C, Hug C (eds): Pharmacokinetics of Anaesthesia. Boston, NIA, Blackwell Scientific Publications, 1984, p 157
11.
Shafer S., Stanski D.: Improving the clinical utility of anesthetic drug pharmacokinetics. Anesthesiology76: 327-330, 1992
12.
Hughes M., Glass P., Jacobs J.: Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology76:334-341, 1992
13.
Newman M., Reves J.: Pro: Midazolam is the sedative of choice to supplement narcotic anesthesia . J Cardiothorac Vasc Anesth7:615-619, 1993
Persson P., Nilson A., Hartvig P., et al: Pharmacokinetics of midazolam in total IV anaesthesia. Br J Anaesth59:548-556, 1987
16.
Klotz U., Reimann I.: Pharmacokinetic and pharmacodynamic interaction study of diazepam and metoprolol . Eur J Clin Pharmacol26:223-226, 1984
17.
Greenblatt D., Divoll M., Harmatz J., et al: Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular and oral lorazepam. J Pharm Sci71:248-252,1982
18.
Elliott H.: Metabolism of lorazepam. Br J Anaesth48:1017-1023, 1976
19.
Greenblatt D. , Shader R.: Benzodiazepines in Clinical Practice. New York, NY, Raven Press, 1974
20.
Shull H., Wilkinson G., Johnson R., et al: Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med84:420-425, 1976
21.
Chinnery R. , Sundwall A.: Pharmacodynamic, pharmacokinetic, and clinical aspects on oxazepam and related benzodiazepines. Acta Psychiatry Scand274:1-128, 1978
22.
Mandelli M. , Tognoni G., Garattini S.: Clinical pharmacokinetics of diazepam. Clin Pharmacokinet3:72-91, 1978
23.
Greenblatt D., Allen M., Harmatz J., et al: Diazepam disposition determinants . Clin Pharmacol Ther27:301-312,1980
24.
Ziegler W., Schalch E., Leishman B., et al: Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites. Br J Clin Pharmacol16:63S-69S, 1983
25.
Heizmann P. , Eckert M., Ziegler W.: Pharmacokinetics and bioavailability of midazolam in man. Br J Clin Pharmacol16:43S-49S, 1983
26.
Ziegler W., Schalch E., Leishman R., et al: Comparison of the effects of intravenously administered midazolam, triazolam and their hydroxy metabolites. Br J Clin Pharmacol16:63S-69S, 1983
27.
Mandema J., Tuk B., van Steveninck A., et al: Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite α-hydroxymidazolam in healthy volunteers. Clin Pharmacol Ther51:715-728, 1992
28.
Klotz U., Reimann I.: Elevation of steady-state diazepam levels by cimetidine. Clin Pharmacol Ther3:513-517, 1981
29.
Greenblatt D., Abernathy D., Morse D., et al: Clinical importance of the interaction of diazepam and cimetidine. N Engl J Med310:1639-1643, 1984
30.
Greenblatt D., Locniskar A., Scavone J., et al: Absence of interaction of cimetidine and ranitidine with intravenous and oral midazolam. Anesth Analg65:176-180, 1986
31.
Hiller A., Olkkola K., Isohanni P., et al: Unconsciousness associated with midazolam and erythromycin. Br J Anaesth65:826-828, 1990
32.
Blitt C.: Clinical pharmacology of lorazepam, in Brown B (ed): New Pharmacologic Vistas in Anesthesia. Philadelphia, PA, Davis, 1983, p 135
33.
Cheng S., Brunner E.: The effects of anesthetic agents on GABA metabolism in rat brain synaposomes , in Hertz L, Kvamme E, McGeer EG, et al (eds): Glutamine, Glutamate, and GABA in the Central Nervous System. New York, NY, Alan R Liss, 1983, p 653
34.
Costa E., Guidotti A.: Molecular mechanisms in the receptor action of benzodiazepines. Ann Rev Pharmacol Toxicol19:531-545, 1979
35.
Olsen R., Fischer J., Dunwiddie T.: Barbiturate enhancement of gamma-aminobutyric acid receptor binding and function as a mechanism of anesthesia, in Roth S, Miller K (eds): Molecular and Cellular Mechanisms of Anesthetics. NewYork, NY, Plenum , 1986, p 165
36.
Fragen R., Avram M.: Nonopioid intravenous anesthetics, in Barash P, Cullen B, Stoelting R (eds): Clinical Anesthesia. Philadelphia, PA, Lippincott, 1992 , pp 385-412
37.
Mendelson W. : Neuropharmacology of sleep induction of benzodiazepines . Neurobiology16:221, 1992
38.
Zorumski C. , Isenberg K.: Insights into the structure and function of GABA-benzodiazepine receptors: Ion channels and psychiatry. Am J Psychiatry148:162-173, 1991
39.
MacDonald R., Skerrit J., Werz M.: Barbiturate and benzodiapine actions on mouse neurons in cell culture, in Roth S, Miller K (eds): Molecular and Cellular Mechanims of Anesthetics . New York, NY, Plenum, 1986, p 7
40.
Reves J., Croughwell ND, Jacobs J., et al: Continuous infusion of fentanyl and midazolam for cardiac surgery . Anesth Analg70:323-325, 1990
41.
Theil D., Stanley T., White W., et al: Midazolam and fentanyl continuous infusion anesthesia for cardiac surgery: A comparison of computer-assisted versus manual infusion systems . J Cardiothorac Vasc Anesth7:300-306, 1993
42.
Reves J., Kissin I., Smith L.: The effective dose of midazolam. Anesthesiology55:82, 1981
43.
Cote P., Noble J., Bourassa M.: Systemic vasodilation following diazepam after combined sympathetic and parasympathetic blockage in patients with coronary heart disease. Cath Cardiovasc Diagn 2:369-380, 1976
44.
Jackson A., Dhadphale P., Callaghan M., et al: Haemodynamic studies during induction of anaesthesia for open-heart surgery using diazepam and ketamine. Br J Anaesth50:375-378, 1978
45.
Samuelson P., Lell W., Kouchoukos N., et al: Hemodynamics during diazepam induction of anesthesia for coronary artery bypass grafting. South Med J73:332-334, 1980
46.
Rao S., Sherbaniuk R., Prasad K., et al: Cardiopulmonary effects of diazepam. Clin Pharmacol Ther14:182-189, 1973
47.
Samuelson P. , Reves J., Kouchoukos N., et al: Hemodynamic responses to anesthetic induction with midazolam in patients with ischemic heart disease. Anesth Analg60:802-809, 1981
48.
Cote P., Gueret P., Bourassa M.: Systemic and coronary hemodynamic effects of diazepam in patients with normal and diseased coronary arteries. Circulation50:1210-1216,1974
49.
Schmucker P. , van Ackern K., Franke N., et al: Einwirkung von intravenous appliziertem lormetazepam auf hamodynamik und arterielle blutgase bei patienten mit koronarer herzekrankkung. Anaesthetist31:557-563, 1982
50.
Ruff R., Reves J.: Hemodynamic effects of a lorazepam-fentanyl anesthetic induction for coronary artery bypass surgery. J Cardiothorac Anesth4:314-317, 1990
51.
D'Amelio G. , Volta S., Stritoni P., et al: Acute cardiovascular effects of diazepam in patients with mitral valve disease. Eur J Clin Pharmacol6:61-63, 1973
52.
Nauta J., Stanley T., de Lange S., et al: Anaesthetic induction with alfentanil: Comparison with thiopental, midazolam and etomidate. Can Anaesth Soc J30:53-60, 1983
53.
Marty J., Nitenberg A., Blancet F., et al: Effects of midazolam on the coronary circulation in patients with coronary artery disease. Anesthesiology64:206-210, 1986
54.
Kwar P., Carson I., Clarke R., et al: Haemodynamic changes during induction of anaesthesia with midazolam and diazepam (Valium) in patients undergoing coronary artery bypass surgery . Anaesthesia40:767-771, 1985
55.
Lebowitz P. , Cote M., Daniels A., et al: Cardiovascular effects of midazolam and thiopentone for induction of anaesthesia in ill surgical patients. Can Anaesth Soc J30:19-23, 1983
56.
Gelman S., Reves J., Harris D.: Circulatory responses to midazolam anesthesia: Emphasis on canine splanchnic circulation. Anesth Analg62:135-139, 1983
57.
Greenblatt D., Sellers E., Shader R.: Drug disposition in old age. N Engl J Med306:1081-1088, 1982
58.
Jacobs J., Reves J., Marty J., et al: Aging increases pharmacodynamic sensitivity to the hypnotic effects of midazolam. Anesth Analg80:143-148, 1995
59.
Bruce A., Andersson M., Arvidsson B., et al: Body composition: Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age. Scand J Clin Lab Invest40:461, 1980
60.
Bender A.: The effect of increasing age on the distribution of peripheral blood flow in man. J Am Geriatr Soc13:192-198, 1965
61.
Avram M., Fragen RJ, Caldwell N.: Midazolam kinetics in women of two age groups. Clin Pharmacol Ther34:505-508, 1983
62.
Greenblatt D., Abernethy D., Locniskar A., et al: Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology61:27-35, 1984
63.
Reves J., Fragen R., Vinik H., et al: Midazolam: Pharmacology and uses. Anesthesiology62:310-324, 1985
64.
Macleod S., Giles H., Bengert B., et al: Age- and gender-related differences in diazepam pharmacokinetics . J Clin Pharmacol19:15-19, 1979
65.
Lamy P.: Physiological changes due to age. Drugs Aging1:385-404,1991
66.
Schmucker D. : Aging and drug disposition: An update. Pharmacol Rev37:133-148, 1985
67.
Short T., Galletly D., Plummer J.: Hypnotic and anaesthetic action of thiopentone and midazolam alone and in combination. Br J Anaesth66:13-19, 1991
68.
Tverskoy M. , Fleyshman G., Bradley E., et al: Midazolam-thiopental interaction in patients. Anesth Analg67:342-345, 1988
69.
Tverskoy M. , Ben-Shlomo I., Ezry J., et al: Midazolam acts synergistically with methohexitone for induction of anaesthesia. Br J Anaesth63:109-112, 1989
70.
McClune S., McKay A., Clarke R.: Midazolam and propofol for induction of anaesthesia. Br J Anaesth67:215P-216P, 1991
71.
Short T., Chui P.: Propofol and midazolam act synergistically in combination. Br J Anaesth67:539-545, 1991
McClune S., McKay A., Wright P., et al: Synergistic interaction between midazolam and propofol. Br J Anaesth69:240-245, 1992
74.
Short T., Plummer J., Chui P.: Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil . BrJ Anaesth69:162-167, 1992
75.
Ben-Shlomo I., Abd-El-Khalim H., Ezry J., et al: Midazolam acts synergistically with fentanyl for induction of anaesthesia. Br J Anaesth64:45-47, 1990
76.
Kissin I., Vinik H., Castillo R., et al: Alfentanil potentiates midazolam-induced unconciousness in subanalgesic doses. Anesth Analg71:65-69, 1990
77.
Vinik H., Bradley E Jr, Kissin I.: Midazolam-alfentanil synergism for anesthetic induction in patients. Anesth Analg69:213-217, 1989
78.
Silbert B., Rosow C., Keegan C., et al: The effect of diazepam on induction of anesthesia with alfentanil . Anesth Analg65:71-77, 1987
79.
Reves J., Croughwell N.: Valium-fentanyl interaction, in Reves J, Hall K (eds): Common Problems in Cardiac Anesthesia . Chicago, IL, Year Book Medical Publishers, 1987, pp 356-361
80.
Stanley T., Webster L.: Anesthetic requirements and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man. Anesth Analg57:411-416,1978
81.
Tomicheck R. , Rosow C., Philbin D., et al: Diazepam-fentanyl interaction: Hemodynamic and hormonal effects in coronary artery surgery. Anesth Analg62:881-884,1983
82.
Stanley T., Bennett G., Loeser E., et al: Cardiovascular effects of diazepam and droperidol during morphine anesthesia. Anesthesiology44:255-258, 1976
83.
Tuman K., McCarthy R., El-Ganzouri A., et al: Sufentanil-midazolam anesthesia for coronary artery surgery . J Cardiothorac Vasc Anesth4:308-313, 1990
84.
Reves J, Gelman S (eds): Cardiovascular effects of intravenous anesthetic drugs, in Effects of Anesthesia, American Physiological Society, 1985, pp 179-193
85.
Pollock J., Kenny G.: Effects of lorazepam on oxygen saturation before cardiac surgery. Br J Anaesth70:219-220, 1993
86.
Marjot R., Valentine S.: Arterial oxygen saturation following premedication for cardiac surgery. Br J Anaesth64:737-740, 1990
87.
Reves J.: Con: Benzodiazepines are not contraindicated as induction agents for coronary artery surgery. J Cardiothorac Anesth2:844-848, 1988
88.
Thompson I. , MacAdams C., Hudson R., et al: Drug interactions with sufentanil . Anesthesiology76:922-929, 1992
89.
Melvin M., Johnson B., Quasha A., et al: Induction of anesthesia with midazolam decreases halothane MAC in humans. Anesthesiology57:238-241, 1982
90.
McNulty S., Gratch D., Kim J.: Comparative vascular effects of midazolam and lorazepam administered during cardiopulmonary bypass. Anesth Analg79:675-680, 1994
91.
McNulty S., Gratch D., Costello D., et al: The effect of midazolam and lorazepam on postoperative recovery after cardiac surgery. Anesth Analg81:404-407, 1995
92.
Reves J., Vinik R., Hirschfield A., et al: Midazolam compared with thiopentone as a hypnotic component in balanced anaesthesia: A randomized double-blind study. Can Anaesth Soc J26:42-49, 1979
93.
Jensen A., Schouu-Olesen A., Huttel M.: Use of midazolam as an induction agent: Comparison with thiopental. Br J Anaesth54:605-607, 1982
94.
Reves J., Sladen R.: Proceedings of a Symposium in Anesthesia and Sedation by Continuous Infusion . Princeton, NJ, Excerpta Medica , 1991
95.
Lowry K., Dundee J., McClean E., et al: Pharmacokinetics of diazepam and midazolam when used for sedation following cardiopulmonary bypass. Br J Anaesth57:833-835, 1985
96.
Mathews H., Carson I., Collier P., et al: Midazolam sedation following open heart surgery. Br J Anaesth59:557-560,1987
97.
Roekaerts P. , Huygen F., de Lange S.: Infusion of propofol versus midazolam for sedation in the intensive care unit following coronary artery surgery. J Cardiovasc Thorac Anesth7:142-147, 1993
98.
Higgins T., Yared J., Estafanous F., et al: Propofol versus midazolam for intensive care unit sedation after coronary artery bypass grafting. Crit Care Med22:1415-1423, 1994
99.
Chaudhri S. , Kenny G.: Sedation after cardiac bypass surgery: Comparison of propofol and midazolam in the presence of a computerized closed loop arterial pressure controller. Br J Anaesth68:98-99, 1992
100.
O'Connor M. , Kress J., Toledano A., et al: Sedation for critically ill patients with midazolam requires less opiate than sedation with propofol. Anesth Analg82:S342, 1996
101.
Glass P., Shafer S., Jacobs J., et al: Intravenous drug delivery systems, in Miller R (ed): Anesthesia. NewYork, NY , Churchill Livingstone, 1994, pp 389-416
102.
Smith B, Reves J (eds): Computer-assisted continuous infusion of intravenous anesthesia drugs. Int Anesth Clin33:1-113, 1995
103.
Kern F., Ungerleider R., Jacobs J., et al: Computerized continuous infusion of intravenous anesthetic drugs during pediatric cardiac surgery. Anesth Analg72:487-492, 1991
104.
Wagner J.: A safe method for rapidly achieving plasma concentration plateaus. Clin Pharmacol Ther16:691-700, 1974
